Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
IL-4/10 prevents stress vulnerability following imipramine discontinuation.
Suppression of IL-10 production by calcitriol in patients with multiple sclerosis.
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.
Signaling networks in MS: A systems-based approach to developing new pharmacological therapies.
Ranolazine Attenuates Mechanical Allodynia Associated with Demyelination Injury.
Cell-specific effects in different immune subsets associated with SOCS1 genotypes in multiple sclerosis.
The primate autoimmune encephalomyelitis model; a bridge between mouse and man.
Goal attainment in cognitive rehabilitation in MS patients.
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Intention tremor and deficits of sensory feedback control in multiple sclerosis: a pilot study.
[Vitamin D and neurology.]
Dual diagnosis: rheumatoid arthritis and multiple sclerosis.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
Pain and spinal cord imaging measures in children with demyelinating disease.
Scutellarin Alleviates Behavioral Deficits in a Mouse Model of Multiple Sclerosis, Possibly Through Protecting Neural Stem Cells.
Chemokines and chemokine receptors in multiple sclerosis.
The essential role of t cells in multiple sclerosis: A reappraisal.
Low maternal exposure to ultraviolet radiation in pregnancy, month of birth, and risk of multiple sclerosis in offspring: longitudinal analysis.
The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis.
Opexa Reaches Enrollment Target in Phase IIb Trial of Personalized Immunotherapy for Secondary Progressive Multiple Sclerosis
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation.
Age-Dependent Decline of Nogo-A Protein in the Mouse Cerebrum.
Endothelial microparticles interact with and support the proliferation of T cells.

Pages